Orthofix International (OFIX) Upgraded to “Hold” at BidaskClub

BidaskClub upgraded shares of Orthofix International (NASDAQ:OFIX) from a sell rating to a hold rating in a report released on Thursday morning.

A number of other research analysts have also weighed in on OFIX. TheStreet lowered shares of Orthofix International from a b rating to a c+ rating in a research note on Tuesday, October 31st. BTIG Research set a $56.00 price target on shares of Orthofix International and gave the company a buy rating in a research note on Monday, October 30th. Finally, Zacks Investment Research raised shares of Orthofix International from a hold rating to a buy rating and set a $60.00 price target on the stock in a research note on Thursday, November 2nd. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. The company has an average rating of Buy and an average target price of $54.42.

Orthofix International (NASDAQ:OFIX) opened at $55.25 on Thursday. The stock has a market cap of $1,010.00, a P/E ratio of 2,762.50, a P/E/G ratio of 2.73 and a beta of 0.14. Orthofix International has a 1-year low of $33.51 and a 1-year high of $56.53.

Orthofix International (NASDAQ:OFIX) last issued its quarterly earnings data on Monday, October 30th. The medical device company reported $0.42 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.41 by $0.01. The firm had revenue of $105.30 million during the quarter, compared to analysts’ expectations of $100.67 million. Orthofix International had a net margin of 0.33% and a return on equity of 10.26%. The business’s revenue for the quarter was up 6.9% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.36 earnings per share. equities research analysts forecast that Orthofix International will post 1.61 earnings per share for the current fiscal year.

In other news, Director Luke T. Faulstick sold 4,800 shares of the business’s stock in a transaction on Monday, November 6th. The shares were sold at an average price of $51.22, for a total value of $245,856.00. Following the sale, the director now owns 7,729 shares of the company’s stock, valued at $395,879.38. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Bradley V. Niemann sold 5,547 shares of the business’s stock in a transaction on Monday, December 11th. The stock was sold at an average price of $52.08, for a total transaction of $288,887.76. Following the completion of the sale, the insider now directly owns 34,631 shares in the company, valued at approximately $1,803,582.48. The disclosure for this sale can be found here. In the last three months, insiders sold 15,347 shares of company stock worth $802,144. 5.60% of the stock is currently owned by insiders.

Hedge funds and other institutional investors have recently bought and sold shares of the business. Pinebridge Investments L.P. raised its position in Orthofix International by 2.3% during the second quarter. Pinebridge Investments L.P. now owns 2,378 shares of the medical device company’s stock worth $111,000 after acquiring an additional 53 shares in the last quarter. Municipal Employees Retirement System of Michigan acquired a new position in shares of Orthofix International in the second quarter valued at $196,000. Los Angeles Capital Management & Equity Research Inc. acquired a new position in shares of Orthofix International in the third quarter valued at $315,000. Invictus RG acquired a new position in shares of Orthofix International in the third quarter valued at $342,000. Finally, BNP Paribas Arbitrage SA increased its holdings in shares of Orthofix International by 64.3% in the second quarter. BNP Paribas Arbitrage SA now owns 7,651 shares of the medical device company’s stock valued at $356,000 after purchasing an additional 2,995 shares during the last quarter. 94.61% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION WARNING: This story was published by Community Financial News and is the property of of Community Financial News. If you are accessing this story on another website, it was copied illegally and republished in violation of US & international copyright law. The original version of this story can be read at https://www.com-unik.info/2017/12/25/orthofix-international-ofix-upgraded-to-hold-at-bidaskclub.html.

Orthofix International Company Profile

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.

Analyst Recommendations for Orthofix International (NASDAQ:OFIX)

Receive News & Ratings for Orthofix International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit